Pharmaceutical lactam compositions for inhibition of erythrocyte

Details Pharmaceutical lactam compositions for inhibition of erythrocyte Pharmaceutical lactam compositions for inhibition of erythrocyte

1991-01-11

1994-12-13

Higel, Floyd D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514424, 514414, 514418, 514415, 548486, 548484, 548454, A61K 3140, B07D20930, B07D20932, B07D20934

Patent

active

053730194

ABSTRACT:
The present invention provides compounds and pharmaceutical compositions containing indolones of the general formula: ##STR1## These indolones where n.dbd.o and the pharmaceutical compositions containing these compounds are used for the treatment of diseases in which erythrocyte and thrombocyte aggregation play an important part, especially for the inhibition of aggregation of these cells.

REFERENCES:
patent: 4985448 (1991-01-01), Zilch et al.
patent: 5019587 (1991-05-01), Von Der Saal et al.

Affiliated with

Also associated with

Rating

Pharmaceutical lactam compositions for inhibition of erythrocyte does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical lactam compositions for inhibition of erythrocyte, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical lactam compositions for inhibition of erythrocyte will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1193673